Inventor · disambiguated record
Claude Benedict
Also filed as: BENEDICT CLAUDE · BENEDICT CLAUDE R
14 granted patents·1 pending application·186 citations·filing 1993–2021
93Inventor score
Top patents by PatentIndex Score
15 records- 0193US7538211B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted May 26, 2009·33 cites·7 claims
- 0292US7803931B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted Sep 28, 2010·19 cites·5 claims
- 0392US7579456B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2006·Granted Aug 25, 2009·24 cites·6 claims
- 0492US7566701B2Aptamers to von Willebrand Factor and their use as thrombotic disease therapeuticsARCHEMIX CORP·Filed 2005·Granted Jul 28, 2009·30 cites·19 claims
- 0588US8236773B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2006·Granted Aug 7, 2012·9 cites·10 claims
- 0687US10947544B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2019·Granted Mar 16, 2021·1 cites·5 claims
- 0786US8436164B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2012·Granted May 7, 2013·6 cites·15 claims
- 0885US7998940B2Aptamers to von Willebrand factor and their use as thrombotic disease therapeuticsARCHEMIX CORP·Filed 2009·Granted Aug 16, 2011·6 cites·19 claims
- 0984US9617546B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2014·Granted Apr 11, 2017·4 cites·5 claims
- 1082US7589073B2Aptamers to von Willebrand Factor and their use as thrombotic disease therapeuticsARCHEMIX CORP·Filed 2006·Granted Sep 15, 2009·4 cites·40 claims
- 1177US11913000B2Aptamer therapeutics useful in the treatment of complement-related disordersIVERIC BIO INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 1275US8946184B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2013·Granted Feb 3, 2015·1 cites·20 claims
- 1370US5426097ACalreticulin: a novel antithrombotic agentUNIV COLUMBIA·Filed 1993·Granted Jun 20, 1995·35 cites·19 claims
- 1462US2018030446A1Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2017·Application pending·0 cites
- 1557US5798372AMethod for preventing onset of restenosis after angioplasty employing a retinoidALLERGAN INC·Filed 1997·Granted Aug 25, 1998·14 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →